Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study.

ABSTRACT:

SUBMITTER: Herling M 

PROVIDER: S-EPMC10874748 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature